益佰制药
(600594)
| 流通市值：26.85亿 | | | 总市值：26.85亿 |
| 流通股本：7.92亿 | | | 总股本：7.92亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 619,878,982.72 | 760,224,074.48 | 770,599,925.85 | 699,468,723.75 |
| 应收票据及应收账款 | 492,605,525.89 | 460,101,668.15 | 536,772,601.21 | 692,318,654.25 |
| 其中：应收票据 | 252,850,526.87 | 239,514,268.79 | 322,402,704.49 | 465,262,911.43 |
| 应收账款 | 239,754,999.02 | 220,587,399.36 | 214,369,896.72 | 227,055,742.82 |
| 应收款项融资 | - | 30,784,183.37 | - | - |
| 预付款项 | 16,376,625.3 | 27,721,544.56 | 55,284,027.18 | 36,213,500.19 |
| 其他应收款合计 | 26,764,565.86 | 35,748,404.64 | 38,820,346.04 | 33,261,349.63 |
| 存货 | 552,834,263.39 | 601,393,051.1 | 614,258,479.5 | 586,650,795.7 |
| 其他流动资产 | 24,157,134.13 | 27,526,097.09 | 19,995,911.78 | 21,234,994.67 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,732,617,097.29 | 1,943,499,023.39 | 2,035,731,291.56 | 2,069,148,018.19 |
| 非流动资产: | | | | |
| 长期股权投资 | 35,220,246.41 | 35,223,733.95 | 35,132,187.03 | 35,070,885.7 |
| 其他权益工具投资 | 1,630,909.7 | 1,630,909.7 | 1,630,909.7 | 1,591,196 |
| 固定资产 | 1,602,010,050.71 | 1,635,309,740.7 | 1,667,453,883.9 | 1,705,684,684.34 |
| 在建工程 | 5,467,637.29 | 6,483,362.58 | 7,247,857.67 | 4,987,715.29 |
| 生产性生物资产 | 15,906,704 | 12,642,500.92 | 9,231,012.45 | 6,249,724.49 |
| 使用权资产 | 31,842,916.24 | 34,031,499.79 | 36,220,083.34 | 38,464,239.8 |
| 无形资产 | 319,018,931.35 | 322,965,362.26 | 326,935,901.96 | 330,887,356.92 |
| 商誉 | 164,038,070.15 | 164,038,070.15 | 164,038,070.15 | 164,038,070.15 |
| 长期待摊费用 | 106,949,892.75 | 111,802,027.02 | 116,870,909.18 | 123,132,285.96 |
| 递延所得税资产 | 85,088,599.9 | 68,705,528.45 | 54,819,746.03 | 55,580,480.5 |
| 其他非流动资产 | 67,366,435.25 | 69,526,386.42 | 67,386,455.23 | 62,419,205.84 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,434,540,393.75 | 2,462,359,121.94 | 2,486,967,016.64 | 2,528,105,844.99 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 4,167,157,491.04 | 4,405,858,145.33 | 4,522,698,308.2 | 4,597,253,863.18 |
| 流动负债: | | | | |
| 短期借款 | 290,825,916.68 | 426,668,613.93 | 446,008,262.5 | 446,045,418.03 |
| 应付票据及应付账款 | 127,423,809.2 | 173,722,391.52 | 182,310,573.73 | 135,057,579.64 |
| 应付账款 | 127,423,809.2 | 173,722,391.52 | 182,310,573.73 | 135,057,579.64 |
| 合同负债 | 25,370,790.73 | 47,469,392.28 | 28,893,761.99 | 29,520,057.54 |
| 应付职工薪酬 | 40,554,697.28 | 34,573,223.27 | 34,826,682.69 | 55,989,426.38 |
| 应交税费 | 37,128,104.93 | 34,396,421.36 | 24,917,137.57 | 28,873,348.46 |
| 其他应付款合计 | 73,306,028.71 | 77,450,367.22 | 88,092,456.19 | 103,804,786.83 |
| 其中:应付利息 | 171,203.52 | 171,203.52 | 171,203.52 | 171,203.52 |
| 一年内到期的非流动负债 | 268,667,309.17 | 266,921,206.45 | 261,345,168.57 | 122,853,384.72 |
| 其他流动负债 | 3,940,001.77 | 6,051,100.72 | 6,642,053.84 | 7,445,638.58 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 867,216,658.47 | 1,067,252,716.75 | 1,073,036,097.08 | 929,589,640.18 |
| 非流动负债: | | | | |
| 长期借款 | 280,795,670.61 | 238,524,504.44 | 248,424,504.44 | 387,224,504.44 |
| 租赁负债 | 24,356,497.53 | 24,256,468.54 | 28,317,252.88 | 30,360,000.47 |
| 长期应付款 | 84,713,594.73 | 85,985,067.2 | 86,747,967.61 | 87,550,948.32 |
| 预计负债 | 271,290.7 | 581,849.74 | 448,511.75 | 520,046.36 |
| 递延收益 | 97,986,937.93 | 100,863,977.02 | 103,220,607.76 | 106,314,449.75 |
| 递延所得税负债 | 35,041,209.08 | 33,340,253.35 | 35,620,649.75 | 37,439,314.78 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 523,165,200.58 | 483,552,120.29 | 502,779,494.19 | 649,409,264.12 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,390,381,859.05 | 1,550,804,837.04 | 1,575,815,591.27 | 1,578,998,904.3 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 791,927,400 | 791,927,400 | 791,927,400 | 791,927,400 |
| 资本公积 | 653,836,676.92 | 653,836,676.92 | 653,836,676.92 | 653,836,676.92 |
| 减:库存股 | 14,997,308 | - | - | - |
| 其他综合收益 | 672,255.73 | 684,787.73 | 684,787.73 | 645,246.9 |
| 盈余公积 | 314,569,579.33 | 314,569,579.33 | 314,569,579.33 | 314,569,579.33 |
| 未分配利润 | 902,047,094.34 | 964,704,939.55 | 1,055,010,773.01 | 1,123,465,581.46 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,648,055,698.32 | 2,725,723,383.53 | 2,816,029,216.99 | 2,884,444,484.61 |
| 少数股东权益 | 128,719,933.67 | 129,329,924.76 | 130,853,499.94 | 133,810,474.27 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,776,775,631.99 | 2,855,053,308.29 | 2,946,882,716.93 | 3,018,254,958.88 |
| 负债和股东权益合计 | 4,167,157,491.04 | 4,405,858,145.33 | 4,522,698,308.2 | 4,597,253,863.18 |
| 公告日期 | 2024-10-26 | 2024-08-24 | 2024-04-19 | 2024-04-19 |
| 审计意见(境内) | | | | 标准无保留意见 |